S.B.H. Kent

1.4k total citations
25 papers, 1.2k citations indexed

About

S.B.H. Kent is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, S.B.H. Kent has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in S.B.H. Kent's work include Chemical Synthesis and Analysis (8 papers), Hepatitis B Virus Studies (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). S.B.H. Kent is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Hepatitis B Virus Studies (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). S.B.H. Kent collaborates with scholars based in United States, Australia and Canada. S.B.H. Kent's co-authors include R. C. Milton, Saskia Milton, A. R. Neurath, Pierre Tiollais, George B. Thornton, Marie‐Louise Michel, David R. Milich, Francis V. Chisari, N. Strick and Ian Clark‐Lewis and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

S.B.H. Kent

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.B.H. Kent United States 15 643 351 276 188 176 25 1.2k
Tsafi Danieli Israel 17 1.1k 1.7× 458 1.3× 141 0.5× 131 0.7× 153 0.9× 31 1.7k
Alfred M. Engel Germany 20 893 1.4× 520 1.5× 119 0.4× 466 2.5× 73 0.4× 39 1.7k
Maurizio Sollazzo Italy 21 804 1.3× 92 0.3× 152 0.6× 188 1.0× 555 3.2× 36 1.2k
Marc C. Deller United States 14 828 1.3× 181 0.5× 328 1.2× 90 0.5× 327 1.9× 18 1.5k
Hung V. Le United States 20 755 1.2× 242 0.7× 104 0.4× 310 1.6× 130 0.7× 55 1.7k
Yoshinao Kubo Japan 18 296 0.5× 244 0.7× 261 0.9× 143 0.8× 82 0.5× 69 1.1k
Chander P. Bahl United States 17 860 1.3× 165 0.5× 38 0.1× 189 1.0× 71 0.4× 28 1.2k
Peter W. White Canada 21 417 0.6× 576 1.6× 107 0.4× 454 2.4× 111 0.6× 46 1.3k
Ľubica Supeková United States 20 1.1k 1.7× 781 2.2× 363 1.3× 835 4.4× 49 0.3× 28 2.4k
Leonid Beigelman United States 27 1.8k 2.8× 176 0.5× 69 0.3× 151 0.8× 75 0.4× 100 2.3k

Countries citing papers authored by S.B.H. Kent

Since Specialization
Citations

This map shows the geographic impact of S.B.H. Kent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.B.H. Kent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.B.H. Kent more than expected).

Fields of papers citing papers by S.B.H. Kent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.B.H. Kent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.B.H. Kent. The network helps show where S.B.H. Kent may publish in the future.

Co-authorship network of co-authors of S.B.H. Kent

This figure shows the co-authorship network connecting the top 25 collaborators of S.B.H. Kent. A scholar is included among the top collaborators of S.B.H. Kent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.B.H. Kent. S.B.H. Kent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kent, S.B.H., et al.. (2003). ESR study of γ-Irradiated N α -Acetyl-L histidine monohydrate. Radiation effects and defects in solids. 158(8). 599–602. 3 indexed citations
3.
Milton, R. C., Saskia Milton, & S.B.H. Kent. (1992). Total Chemical Synthesis of a D-Enzyme: The Enantiomers of HIV-1 Protease Show Reciprocal Chiral Substrate Specificity. Science. 256(5062). 1445–1448. 333 indexed citations
4.
Milton, R. C., Saskia Milton, & S.B.H. Kent. (1992). Total Chemical Synthesis of a D-Enzyme: The Enantiomers of HIV-1 Protease Show Demonstration of Reciprocal Chiral Substrate Specificity. 256(5062). 1445–1448. 39 indexed citations
5.
Suyama, K, Jordan Goldstein, R Aebersold, & S.B.H. Kent. (1991). Regarding the size of Rh proteins [letter]. Blood. 77(2). 411–411. 9 indexed citations
6.
Kent, S.B.H., et al.. (1991). Inhibition of intercellular adhesion molecule 1-dependent biological activities by a synthetic peptide analog.. Proceedings of the National Academy of Sciences. 88(7). 2879–2882. 28 indexed citations
7.
Neurath, A. R., S.B.H. Kent, N. Strick, & K. Parker. (1988). Delineation of contiguous determinants essential for biological functions of the pre-S sequence of the hepatitis B virus envelope protein: Its antigenicity, immunogenicity and cell-receptor recognition. Annales de l Institut Pasteur Virologie. 139(1). 13–38. 17 indexed citations
8.
Ziltener, Hermann J., Ian Clark‐Lewis, Barbara Fazekas de St Groth, et al.. (1988). Monoclonal antipeptide antibodies recognize IL-3 and neutralize its bioactivity in vivo.. The Journal of Immunology. 140(4). 1182–1187. 18 indexed citations
9.
Clark‐Lewis, Ian, Angel F. López, L. Bik To, et al.. (1988). Structure-function studies of human granulocyte-macrophage colony-stimulating factor. Identification of residues required for activity.. The Journal of Immunology. 141(3). 881–889. 55 indexed citations
10.
Kent, S.B.H. & Ian Clark‐Lewis. (1987). ChemInform Abstract: Modern Methods for the Chemical Synthesis of Biologically Active Peptides. ChemInform. 18(8). 9 indexed citations
11.
Ziltener, Hermann J., Ian Clark‐Lewis, Barbara Fazekas de St Groth, et al.. (1987). Antipeptide antibodies define the NH2-terminal structure of the pan-specific hemopoietin interleukin 3.. The Journal of Immunology. 138(4). 1105–1108. 15 indexed citations
13.
Ziltener, Hermann J., Ian Clark‐Lewis, L Hood, S.B.H. Kent, & John W. Schrader. (1987). Antipeptide antibodies of predetermined specificity recognize and neutralize the bioactivity of the pan-specific hemopoietin interleukin 3.. The Journal of Immunology. 138(4). 1099–1104. 23 indexed citations
14.
Aebersold, R, David B. Teplow, Leroy Hood, & S.B.H. Kent. (1986). Electroblotting from immobiline isoelectric focusing gels for direct protein sequence determination. 715–718. 2 indexed citations
15.
Neurath, A. R. & S.B.H. Kent. (1986). Requirements for successful synthetic peptide vaccines. Annales de l Institut Pasteur Virologie. 137. 513–514. 2 indexed citations
16.
Kempe, Tomas, S.B.H. Kent, Flora Chow, et al.. (1985). Multiple-copy genes: production and modification of monomeric peptides from large multimeric fusion proteins. Gene. 39(2-3). 239–245. 41 indexed citations
17.
Milich, David R., George B. Thornton, A. R. Neurath, et al.. (1985). Enhanced Immunogenicity of the Pre-S Region of Hepatitis B Surface Antigen. Science. 228(4704). 1195–1199. 272 indexed citations
18.
Neurath, A. R., S.B.H. Kent, & N. Strick. (1984). Monoclonal antibodies to hepatitis B surface antigen (HBsAg) with anti-a specificity recognize a synthetic peptide analogue (S135–155) with unmodified lysine (141). Journal of Virological Methods. 9(4). 341–346. 5 indexed citations
19.
Kent, S.B.H.. (1982). New treatments for depression.. PubMed. 37(11). 149–51. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026